A number of promising solid implant applications can also be found in ophthalmology for the treatment of back of the eye diseases using steroid, with products in development for the treatment of glaucoma (prostaglandins) and age-related macular degeneration (anti-VEGF).

Other novel drug delivery forms such as intrauterine devices (IUDs) and intravaginal rings (IVRs) and are finding increasing applications in the area of women’s health.  ProMed is working with leading companies and research groups in this area on IVRs for contraception, hormone replacement therapy, and HIV.  Emerging applications in fertility, oncology, and treatment of fibroids are also being explored.  In particular, ProMed has demonstrated core-sheath and multi-segment IVR design capable of delivering multiple APIs over a wide range of drug loads and release rates.